Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.

NCT07538960

Conditions: Cutaneous, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Hospital México San José, Uruca, Costa Rica

View Trial Details

Not yet recruiting

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

NCT07539610

Conditions: B Acute Lymphoblastic Leukemia/Lymphoma, B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: Institute of Hematology, Chinese Academy of Medical Sciences & Hospital of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

NCT07535710

Conditions: Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Not yet recruiting

BR101 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07537049

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Not yet recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT07535762

Conditions: Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Not yet recruiting

Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

NCT07476105

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, +10 more
Locations: Azienda Ospedaliero Universitaria delle Marche - S.O.D. Clinica Ematologica Ancona, Italy

A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy

I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy

I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy

View all 24 locations

View Trial Details

Not yet recruiting

Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.

NCT07529223

Conditions: Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU de Nice Nice, CHU de Nice, France

APHM Marseille, France

View Trial Details

Not yet recruiting

A Study of VG712 in Patients With Mycosis Fungoides

NCT07529405

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Not yet recruiting

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

NCT07516353

Conditions: ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not yet recruiting

Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

NCT07518654

Conditions: Hematologic Diseases, Hematopoetic Stem Cell Transplant, Hematopoetic Stem Cell Transplantation, +32 more
Locations: The Hospital for Sick Children Toronto, Ontario, Canada

CHU Sainte-Justine Montreal, Quebec, Canada

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions